AXL and neoplasm: In various cancer types, increased expression or activation of Axl contributes to tumour progression and treatment resistance by affecting various major signalling pathways (Wang et al., 2013; Park et al., 2015; Zhang et al., 2017; Grit et al., 2020; Hahn et al., 2021).